On May 23, 2018, a Decree was published in the Mexican Official Diary announcing that the Mexican Senate has officially approved the CPTPP.

Eleven countries have signed the free trade agreement formerly known as the Trans-Pacific Partnership (TPP), which has been renamed the "Comprehensive and Progressive Agreement for Trans-Pacific Partnership" (CPTPP). Mexico signed the agreement on March 8, 2018.

The other signing members are: Australia, Brunei, Canada, Chile, Japan, Malaysia, New Zealand, Peru, Singapore and Vietnam.

The Treaty will enter into force 60 days after the date on which at least 6 or at least 50 percent of the number of signatories to the Treaty, whichever is less, have notified the Depositary in writing that the applicable legal requirements have been met.

For any signatory to the CPTPP for which the Treaty has not entered into force as previously mentioned, it shall enter into force 60 days after the date on which that signatory has notified the Depositary in writing that the applicable legal requirements have been met.

We expect the CPTPP to enter into force within the last trimester of 2018 in Mexico.

For background on key differences between the original TPP and the CPTPP, please refer to our Newsletter No. 4, dated March 2018:
http://www.olivares.mx/impact-of-the-comprehensive-and-progressive-agreement-for-trans-pacific-partnership-on-life-sciences-in-mexico/

In total, 22 provisions on rules are suspended. One of the most significant revisions was in the intellectual property (IP) chapter. Under the revised IP chapter, the length of patent protection for innovative medicines and copyright periods for written materials has been shortened, and technology and information protections have been narrowed.

The suspended provisions have removed the additional requirements (pursued by the United States) in technological protection measures (TPMs), rights management information, encrypted satellite and cable signals, and safe harbors for internet service providers (ISPs).

Although the agreement will not be as positive as expected with respect to elevating IP standards in Mexico, it remains a welcome development for international trade and for certain aspects of IP protection and regulatory matters.

FOR FURTHER INFORMATION ON THE CONTENT OF THIS NEWSLETTER, PLEASE CONTACT:

Alejandro Luna Fandiño

Alejandro Luna Fandiño

Partner

Alejandro Luna joined OLIVARES in 1996 and being made partner in 2005, he has been instrumental to the firm´s IP Litigation, Regulatory and Administrative Litigation practices. He co-chairs the Life Sciences & Pharmaceutical Law industry group and coordinates the Litigation Department.
Armando Arenas

Armando Arenas

Partner

Armando Arenas joined OLIVARES in 2000 and became a partner in January 2017. He has experience working on a range of IP matters, including consulting and litigation on trademark, patent, unfair competition, trade dress protection, and misleading advertising cases before the Mexican Institute of Industrial Property (IMPI), Federal Court of Tax and Administrative Affairs (FCTA), Federal Circuit Courts (FCC) and the Supreme Court of Justice (SCJ) Regulatory Affairs and Public Acquisitions.
Daniel Sánchez

Daniel Sánchez

Partner

Daniel Sanchez joined OLIVARES in 2000 and became a partner in 2011. He is one of the leading intellectual property (IP) and administrative litigators in Mexico and is recognized by industry rankings and publications.
Gustavo A. Alcocer

Gustavo A. Alcocer

Partner

Gustavo Alcocer manages the Corporate and Commercial Law Group at OLIVARES, advising domestic and foreign businesses and the owners of those businesses on Mexican and cross-border corporate and commercial transactions.
Sergio L. Olivares Sr.

Sergio L. Olivares Sr.

Partner

Sergio L. Olivares Sr. joined OLIVARES in 1987 and today leads the firm with strength and a commitment to transparency, client satisfaction, and personal service. He has been a partner since 1994 and Chairman of the Management Committee since 2009.

WHO CAN BE FOUND AT THE FOLLOWING NUMBER:

+52(55) 5322 3000
Go Back Top